Impact of autoantibody-mediated procoagulant platelets and thrombus formation in antiphospholipid syndrome

Hamostaseologie 2024; 44(S 01): S15
DOI: 10.1055/s-0044-1779077

Abstracts

Topics

T-03. Pathomechanisms of thrombosis

C. Schnaidt

¹University Hospital Tübingen, Institute for Clinical and Experimental Transfusion Medicine, Tübingen, Germany

,

J. Zlamal

¹University Hospital Tübingen, Institute for Clinical and Experimental Transfusion Medicine, Tübingen, Germany

²University Hospital Tübingen, Center for Clinical Transfusion Medicine, Tübingen, Germany

,

T. Bakchoul

¹University Hospital Tübingen, Institute for Clinical and Experimental Transfusion Medicine, Tübingen, Germany

²University Hospital Tübingen, Center for Clinical Transfusion Medicine, Tübingen, Germany

References
1 Ruiz-Irastorza G, Crowther M, Branch W, Khamashta MA.. 'Antiphospholipid syndrome'. Lancet. 2010; 376 (9751) 1498-509
2 Knight JS, Kanthi Y.. 'Mechanisms of immunothrombosis and vasculopathy in antiphospholipid syndrome'. Semin Immunopathol 2022; 44 (03) 347-362
3 Ho Y., Ahuja K., Körner H., Adams M.. 'β2GP1, Anti-β2GP1 Antibodies and Platelets: Key Players in the Antiphospholipid Syndrome'. Antibodies (Basel) 2016; 5 (02) 12
4 McDonnell T., Wincup C., Buchholz I.. et al. 'The role of beta-2-glycoprotein I in health and disease associating structure with function: More than just APS'. Blood Rev 2020; 39: 100610
5 Baroni G, Banzato A, Bison E, Denas G, Zoppellaro G, Pengo V.. 'The role of platelets in antiphospholipid syndrome'. Platelets 2017; 28 (08) 762-766